FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)

View source ↗

Summary

The FDA approved a supplemental application for QUTENZA (capsaicin) submitted by Averitas Pharma Inc, resulting in a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

SUPPL AP for QUTENZA (CAPSAICIN)